Viatris Inc. -- Moody's: Viatris' biosimilars transaction is credit positive but tempered by core earnings pressure and ongoing cash outlays - Yahoo Finance


2/28/2022 12:00:00 AM3 years 2 months ago
by Moody's

Announcement: Moody's: Viatris' biosimilars transaction is credit positive but tempered by core earnings pressure and ongoing cash outlaysGlobal Credit...

Announcement: Moody's: Viatris' biosimilars transaction is credit positive but tempered by core earnings pressure and ongoing cash outlaysGlobal Credit Research - 28 Feb 2022New… [+10564 chars]

full article...